BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30380557)

  • 1. A Novel Inhibitor of Homodimerization Targeting MyD88 Ameliorates Renal Interstitial Fibrosis by Counteracting TGF-β1-Induced EMT in Vivo and in Vitro.
    Liu JH; He L; Zou ZM; Ding ZC; Zhang X; Wang H; Zhou P; Xie L; Xing S; Yi CZ
    Kidney Blood Press Res; 2018; 43(5):1677-1687. PubMed ID: 30380557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibition of MyD88 homodimerization counteracts renal ischemia reperfusion-induced progressive renal injury in vivo and in vitro.
    Zhang LM; Liu JH; Xue CB; Li MQ; Xing S; Zhang X; He WT; Jiang FC; Lu X; Zhou P
    Sci Rep; 2016 Jun; 6():26954. PubMed ID: 27246399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.
    Xie L; Jiang FC; Zhang LM; He WT; Liu JH; Li MQ; Zhang X; Xing S; Guo H; Zhou P
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26712311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MyD88 inhibitor TJ-M2010-2 suppresses proliferation, migration and invasion of breast cancer cells by regulating MyD88/GSK-3β and MyD88/NF-κB signalling pathways.
    Liu JH; Chen C; Li ZY; Zou ZM; Gao DC; Zhang X; Kuang XW; Sun ZH; Zheng WJ; Zhou P; Sun SR
    Exp Cell Res; 2020 Sep; 394(2):112157. PubMed ID: 32610185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total flavonoids from Smilax glabra Roxb blocks epithelial-mesenchymal transition and inhibits renal interstitial fibrosis by targeting miR-21/PTEN signaling.
    Luo Q; Cai Z; Tu J; Ling Y; Wang D; Cai Y
    J Cell Biochem; 2019 Mar; 120(3):3861-3873. PubMed ID: 30304552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salidroside Ameliorates Renal Interstitial Fibrosis by Inhibiting the TLR4/NF-κB and MAPK Signaling Pathways.
    Li R; Guo Y; Zhang Y; Zhang X; Zhu L; Yan T
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30836660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursolic acid inhibits epithelial-mesenchymal transition in vitro and in vivo.
    Xu CG; Zhu XL; Wang W; Zhou XJ
    Pharm Biol; 2019 Dec; 57(1):169-175. PubMed ID: 30905239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term use of MyD88 inhibitor TJ-M2010-5 prevents d-galactosamine/lipopolysaccharide-induced acute liver injury in mice.
    Ding Z; Du D; Yang Y; Yang M; Miao Y; Zou Z; Zhang X; Li Z; Zhang X; Zhang L; Wang X; Zhao Y; Jiang J; Jiang F; Zhou P
    Int Immunopharmacol; 2019 Feb; 67():356-365. PubMed ID: 30583234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.
    Li C; Zhang LM; Zhang X; Huang X; Liu Y; Li MQ; Xing S; Yang T; Xie L; Jiang FC; Jiang HY; He WT; Zhou P
    Transplantation; 2017 Feb; 101(2):284-293. PubMed ID: 27607533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond knockout: A novel homodimerization-targeting MyD88 inhibitor prevents and cures type 1 diabetes in NOD mice.
    Zhang X; Xing S; Li M; Zhang L; Xie L; He W; Liu J; Chang S; Jiang F; Zhou P
    Metabolism; 2016 Sep; 65(9):1267-77. PubMed ID: 27506734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
    Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-beta1 signal transduction pathway in vivo and in vitro.
    Wang QL; Tao YY; Yuan JL; Shen L; Liu CH
    BMC Cell Biol; 2010 May; 11():31. PubMed ID: 20441599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TJ-M2010-5, A self-developed MyD88 inhibitor, attenuates liver fibrosis by inhibiting the NF-κB pathway.
    Xie Y; Du D; Zhang L; Yang Y; Zou Z; Li Z; Zhou L; Shang R; Zhou P
    Chem Biol Interact; 2022 Feb; 354():109839. PubMed ID: 35101388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating the conformation of the TIR domain by a neoteric MyD88 inhibitor leads to the separation of GVHD from GVT.
    Xing S; Zhang X; Huang X; Xie L; Jiang F; Zhou P
    Leuk Lymphoma; 2019 Jun; 60(6):1528-1539. PubMed ID: 30501537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liuwei Dihuang Decoction Drug-containing Serum Attenuates Transforming Growth Factor-β1-induced Epithelial-mesenchymal Transition in HK-2 Cells by Inhibiting NF-κB/Snail Signaling Pathway.
    Pan J; Jiang Y; Huang Y; Zhang H; Wang X; Luo C; Wang H; Tang M; Pei G; Tang Q
    Curr Pharm Biotechnol; 2023; 24(12):1589-1602. PubMed ID: 36852808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha1-Antitrypsin Attenuates Renal Fibrosis by Inhibiting TGF-β1-Induced Epithelial Mesenchymal Transition.
    Cho JH; Ryu HM; Oh EJ; Yook JM; Ahn JS; Jung HY; Choi JY; Park SH; Kim YL; Kwak IS; Kim CD
    PLoS One; 2016; 11(9):e0162186. PubMed ID: 27607429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TJ-M2010-5 Attenuates Severe Myocardial Ischemia/Reperfusion Injury in Heart Transplantation by Inhibiting MyD88 Homodimerization In Vivo.
    Yang H; Zhou P; Li Q; Zhou X; Li J; Wang J; Wang J; Zhao Y; Yang B; Zhang B; Dai C; Zou Z; Yang Y; Chen Z
    J Cardiovasc Transl Res; 2022 Dec; 15(6):1366-1376. PubMed ID: 35411418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulatory peptide apelin: a novel inhibitor of renal interstitial fibrosis.
    Wang LY; Diao ZL; Zhang DL; Zheng JF; Zhang QD; Ding JX; Liu WH
    Amino Acids; 2014 Dec; 46(12):2693-704. PubMed ID: 25164121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
    Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
    Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMP-2 suppresses renal interstitial fibrosis by regulating epithelial-mesenchymal transition.
    Yang YL; Ju HZ; Liu SF; Lee TC; Shih YW; Chuang LY; Guh JY; Yang YY; Liao TN; Hung TJ; Hung MY
    J Cell Biochem; 2011 Sep; 112(9):2558-65. PubMed ID: 21590708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.